Search

everythinglearnresearchcommunity

for

Search:↓

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Akt2 and SGK3 are both important for normal hair growth and development.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

Sgk3 is essential for normal hair follicle growth and maintenance.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

CXCR2 in skin cells promotes tumor growth.

Anti-CD19 therapy may help treat SLE and NMOSD.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Keratins K6 and K16 are expressed more freely in regenerating mouse skin than K1 and K10.

Blocking certain proteins on immune cells may help treat alopecia areata.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

BST2 is a key marker for hair loss disease alopecia areata.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Certain immune cells, when activated by specific signals, can encourage hair growth.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Blocking S100A8 can reduce chemotherapy-induced hair loss.

Nestin-expressing blood vessels help skin transplants survive and heal.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

CD98hc's role in skin health decreases with age.

Gene knockout mice developed scars similar to human hypertrophic scars, useful for studying scar progression.

Soluble CD83 speeds up wound healing and reduces scarring.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.